Current stock page

Financial Data

SEPN Financial Data

Revenue · Earnings · Margins · Balance Sheet · Cash Flow

HealthcareBiotechnologyScore data as of Nov 13, 2026

SEPNSepterna Inc

Healthcare / Biotechnology

Leader

Strong Relative Position

BullishEdge 8/10
$42.60+$0.74 (+1.77%)

Latest quote

  • Momentum
    87
  • Value
    55
  • Quality
    66
  • Risk resilience
    52
  • Sentiment
    —
algovestiq.comScore data as of Nov 13, 2026

Financial Data Overview

Detailed revenue, earnings, margins, balance sheet, cash flow, valuation metrics, technical indicators, and risk measures for deeper research.

Quarterly periods
8
Fundamental metrics
10
Technical indicators
12
Risk measures
6

Quarterly Financial Statements

Updated Nov 16, 2026.

Income statement
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Revenue$18.88M$26.75M$26.52M$24.12M$21.5M$119K$219K$212K
Gross Profit$18.88M$26.75M$26.1M$24.12M$21.5M$119K$219K$212K
Operating Income-$27.23M-$16.84M-$13.3M-$16.02M$2.61M-$28.98M-$25.91M-$24.72M
Net Income-$26.59M-$13.03M-$8.64M-$10.74M$8.17M-$24.84M-$21.48M-$20.67M
EPS-$0.57-$0.29-$0.19-$0.24$0.18-$0.56-$0.49-$0.64
Cash flow statement
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Operating Cash Flow-$13.77M-$22.18M-$25.63M-$14.99M$168.81M-$20.29M-$23.34M-$20.96M
Capital Expenditure-$127K$0-$832K-$65K-$13K-$58K-$382K-$612K
Free Cash Flow-$13.9M-$22.18M-$26.47M-$15.05M$168.79M-$20.35M-$23.73M-$21.57M
Net Cash Provided By Operating Activities-$13.77M-$22.18M-$25.63M-$14.99M$168.81M-$20.29M-$23.34M-$20.96M
Balance sheet
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Total Assets$619.4M$566.74M$569.69M$596.19M$606.65M$415.23M$434.02M$456.55M
Total Debt$21.99M$22.55M$23.09M$23.63M$24.11M$24.57M$25.03M$25.48M
Cash And Cash Equivalents$167.12M$84.66M$71.61M$120.72M$319.99M$189.31M$210.05M$238.2M
Total Liabilities$191.48M$180.02M$191.23M$214.26M$217.92M$37.67M$33.75M$36.51M
Total Stockholders Equity$427.93M$386.72M$378.46M$381.93M$388.73M$377.56M$400.27M$420.05M
Key financial metrics
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
P/E ratio————————
P/B ratio5.564.522.793.372.121.34——
P/S ratio20.76———————
Debt To Equity0.050.060.060.060.060.070.060.06
Free Cash Flow Yield-3.26%6.01%10.14%8.53%12.50%-16.36%——
Financial ratios
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
P/E ratio————————
P/B ratio5.564.522.793.372.121.34——
P/S ratio20.76———————
Return On Equity-13.79%-6.27%-9.52%-12.80%-15.13%-23.18%-19.76%-17.09%
Debt To Equity0.050.060.060.060.060.070.060.06

Current Stock Metrics

Current fundamental, technical, and risk readings in one place.

Fundamental metrics
MetricValue
Pe-33.02x
Pb4.67x
Revenue Growth Yoy-12.16%
EPS Growth Yoy-416.67%
Gross Margin99.56%
Operating Margin-76.23%
ROE-14.98%
ROIC-14.19%
Debt To Equity0.05
FCF Yield-3.83%

As of Nov 13, 2026

Technical indicators
MetricValue
Close$42.60
Volume337,794
RSI (14)47.95
MACD1.91
MACD signal2.2
MACD histogram-0.29
ADX (14)18.14
SMA (50)$40.46
SMA (200)$33.12
ATR (14)$3.40
Historical volatility (annualized)81.79%
Volume (20-day average)427,169

As of Nov 13, 2026

Risk measures
MetricValue
Resilience score52/100
Beta1.01
Annual volatility69.35%
Max Drawdown-25.98%
Sharpe Ratio1.43
VaR (95%, 1-day)-5.15%

As of Nov 13, 2026

Detailed Metrics

Additional measures remain available here while the decision pages stay focused.

Additional fundamental metrics

No additional fundamental metrics are available.

Additional technical indicators

No additional technical indicators are available.

Additional risk measures

No additional risk measures are available.

SEPN Financial Data FAQ

What is Septerna Inc's revenue?

Septerna Inc's revenue is one of the core financial data points for SEPN. Use it with revenue growth, margins, and EPS to understand whether sales are translating into earnings power.

Is Septerna Inc's revenue growing?

Revenue growth shows whether Septerna Inc is expanding from prior periods. Compare growth with margins and free cash flow because faster sales growth is more valuable when profitability holds up.

What is SEPN's EPS?

SEPN's EPS, or earnings per share, helps connect net income to each share. EPS should be compared with EPS growth, P/E ratio, and analyst expectations.

What is Septerna Inc's net income?

Septerna Inc's net income shows profit after costs, taxes, and other expenses. It should be read with revenue, operating margin, EPS, and free cash flow.

How much free cash flow does Septerna Inc generate?

Free cash flow shows how much cash Septerna Inc generates after capital spending. It is useful for judging reinvestment capacity, buybacks, debt reduction, and valuation support.

How much cash and debt does Septerna Inc have?

Cash and debt help frame SEPN's balance-sheet flexibility. Compare liquidity and leverage with free cash flow and profitability before judging financial strength.